Imperial College London

ProfessorMichaelSchneider

Faculty of MedicineNational Heart & Lung Institute

Chair in Cardiology
 
 
 
//

Contact

 

+44 (0)20 7594 3027m.d.schneider Website

 
 
//

Assistant

 

Miss Cassie Tarquini +44 (0)20 7594 3020

 
//

Location

 

336ICTEM buildingHammersmith Campus

//

Summary

 

Awards

  • 7th Annual Jeffrey Isner Memorial Lecture, Tufts University, 2012
  • Robert Beamish Leadership Award, Institute of Cardiovascular Sciences, University of Manitoba, 2012
  • Annual Clinical School Lecture, Cambridge Medical Society, Addenbrooke’s Hospital, Cambridge University, 2011
  • Don W. Chapman Lecture, Baylor College of Medicine, 2011
  • Mikamo Lecture, Japanese Circulation Society, 2011
  • Distinguished Alumnus Award, Duke Medical Alumni Association, 2010
  • Fellow, European Society of Cardiology, 2010
  • Keynote Speaker, Fall Annual Research Forum, Department of Molecular and Integrative Physiology, University of Michigan, 2005
  • Advanced Investigator Grant, European Research Council, 2008
  • CARIM/Robert Reneman Lecture, Cardiovascular Research Institute Maastricht, 2001
  • Co-organizer, Keystone Symposium, Molecular Mechanisms of Cardiac Disease and Regeneration, 2006
  • Distinguished Achievement Award, American Heart Association Council on Basic Cardiovascular Sciences, 2007
  • Distinguished Visiting Professor, Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, 2003
  • Established Investigator Award, American Heart Association, 1993
  • Fellow, Academy of Medical Sciences, 2009
  • Fellow, American Heart Association, 2001
  • Founding Fellow, International Society for Heart Research, 2001
  • Isadore E. Smith Lecture, Heart and Stroke Richard Lewar Centre of Excellence, University of Toronto, 2007
  • Keynote Lecturer, Stem Cell Network (Canada), 2008
  • Keynote Lecturer, Japanese Circulation Society, 2008
  • Keynote Lecturer, British Cardiovascular Society, 2008
  • Lyndon Baines Johnson Award for Outstanding Research, American Heart Association Texas Affiliate, 1986
  • Medical Futures Cardiovascular Translational Research Innovation Award, 2008
  • Member, Association of American Physicians, 1998
  • Member, American Society for Clinical Investigation, 1991
  • Michael E. DeBakey, M. D., Award for Excellence in Research, Baylor College of Medicine, 2003
  • Organizer, Keystone Symposium on Cardiac Disease: Development, Regeneration, and Repair, 2009
  • Robert E. Davies Distinguished Lecture, Pennsylvania Muscle Institute, University of Pennsylvania, 2004
  • Royal Society Wolfson Research Merit Award, 2007
  • Sheila and Don Bayne Cardiovascular Genetics Endowed Lectureship, Ottawa Heart Institute, University of Ottawa, 2009

External Positions

  • Expert Witness, Science and Technology Committee Inquiry on Regenerative Medicine, House of Lords, 2012 - 2012
  • Scientific Advisory Committee, Frontiers in CardioVascular Biology 2012 Congress, European Society of Cardiology, 2011 - 2012
  • Panel Member, Expert Review Group for Physiology in Health and Disease (ERG6), Wellcome Trust, 2010
  • Panel Member, LS4–Physiology, Pathophysiology and Endocrinology, European Research Council, 2010
  • Member, Advisory Group for Regenerative Medicine (RegenMed), Technology Strategy Board-MRC-BBSRC-EPSRC, 2009
  • Governor, Royal Brompton and Harefield Trust, 2009
  • Scientific Advisory Committee, “Frontiers in Cardiovascular Biology,” First Meeting of the European Society of Cardiology Council on Basic Cardiovascular Science, 2009
  • MRC Council, 2008
  • Planning Committee, 2nd NHLBI Symposium on Cardiovascular Regenerative Medicine, National Institutes of Health, 2007 - 2007
  • International Advisory Board, Excellence Cluster Cardiopulmonary System, Deutsche Forschungsgemeinschaft, 2007
  • Executive Planning Committee, NHLBI Strategic Plan, National Institutes of Health, 2006 - 2006
  • Scientific Advisory Board, European Union 6th Framework Program, “HeartRepair”, 2006 - 2010
  • Scientific Advisory Board, EU 6th Framework Program, HeartRepair, 2006 - 2010
  • Scientific Advisory Board, Stem Cell Network (Canada), 2006
  • Founding Organizer, Annual Symposium of the AHA Council on Basic Cardiovascular Sciences, 2004 - 2004
  • Consultant, Cellular, Tissue and Gene Therapies Advisory Committee, US Food and Drug Administration, 2004 - 2010
  • Scientific Advisory Board, Victor Chang Cardiac Research Institute, Sydney, Australia, 2004 - 2004
  • Council, International Society for Heart Research, 1998 - 2004
  • Leadership Committee, AHA Council on Basic Cardiovascular Sciences, American Heart Association, 1998 - 2006

Industrial Connections

  • GlaxoSmithKline, Consultant, CVU Centre of Excellence for Drug Discovery
  • GlaxoSmithKline, Consultant, Metabolic Pathways Centre of Excellence for Drug Discovery
  • MG Biotherapeutics, Consultant
  • Novartis Institutes of BioMedical Research, Consultant

Commercial Spinoffs

  • Kardia Therapeutics, Founder and Board Member

Editorial Boards

  • npj Regenerative Medicine, Advisory Board
  • Circulation Research, Series Guest Editor, “Regulation of cardiovascular lineage commitment during development and regeneration”, 2010 - 2010
  • Circulation Research, Editorial Board, 1992
  • Journal of Clinical Investigation, Editorial Board, 1999
  • Journal of Molecular and Cellular Cardiology, Editorial Board, 2008
  • Journal of Biological Chemistry, Editorial Board, 2002 - 2005
  • American Journal of Physiology: Heart and Circulatory Physiology, Associate Editor, 1993 - 1998
  • Circulation, Associate Editor, 1993 - 2004
  • Journal of Molecular and Cellular Cardiology, Associate Editor, 1999 - 2007